Target intelligence / Profile preview

Tryptophanyl-tRNA synthetase, mitochondrial (WARS2)

Target
WARS2
Molecular classification
Enzyme, Mitochondrial aminoacyl-tRNA synthetase, Ligase
01

Overview

Tryptophanyl-tRNA synthetase, mitochondrial (WARS2), is an enzyme encoded by the WARS2 gene that catalyzes the attachment of tryptophan to its cognate mitochondrial tRNA, a critical step in mitochondrial protein synthesis. This enzyme is a nucleus-encoded mitochondrial protein and part of the aminoacyl-tRNA synthetase family, essential for translating mitochondrial genes into proteins necessary for oxidative phosphorylation and overall cellular energy metabolism. Two forms of tryptophanyl-tRNA synthetase exist in humans: a cytoplasmic form (WARS/WARS1) and a mitochondrial form (WARS2). Mutations in WARS2 have been linked to autosomal recessive intellectual disability, severe early-onset leukoencephalopathy, and movement disorders, confirming its crucial importance in neural development and mitochondrial function. Beyond its canonical aminoacylation role, WARS2 (and related synthetases) may influence angiogenesis and other cellular processes

Other names
Tryptophan--tRNA ligase, mitochondrialTrpRSmtTrpRSTryptophanyl-tRNA synthetase 2, mitochondrialWARS2NEMMLASPKDYS3tryptophan tRNA ligase 2, mitochondrial
02

Mechanism of action

Not applicable (no approved drugs act directly on WARS2); Mechanisms would involve inhibition or modulation of enzymatic activity if targeted

03

Biological functions

Protein synthesisMitochondrial translationAminoacylation of tRNARegulation of angiogenesis (non-canonical)Cellular metabolism
04

Disease associations

Neurodevelopmental disorder with abnormal movements and lactic acidosis (with or without seizures)Parkinsonism-dystonia 3, childhood-onsetSevere infantile-onset leukoencephalopathySome evidence for roles in cancer and cardio-metabolic disease through GWAS associations
05

Safety considerations

Essential role in mitochondrial translation means inhibition or loss-of-function can cause severe systemic/neurologic dysfunctionLoss-of-function is associated with neurodevelopmental and leukoencephalopathy syndromes
06

Interacting drugs

None directly reported

1 more in the full profile.

07

Biomarkers

WARS2 gene mutations/variants in the context of specific mitochondrial or neurodevelopmental syndromes

Beyond the preview

Go deeper on Tryptophanyl-tRNA synthetase, mitochondrial (WARS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tryptophanyl-tRNA synthetase, mitochondrial (WARS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call